Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mediwound Ltd Ord Sh (MDWD)

Mediwound Ltd Ord Sh (MDWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mediwound Ltd Ord Sh 42 HAYARKON STREET YAVNE L3 8122745 ISR

P: 972-77-971-4100 F: 972-779-7141

Description:

MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. is headquartered in Yavne, Israel.

Key Statistics

Overview:

Market Capitalization, $K 79,924
Enterprise Value, $K 68,874
Shares Outstanding, K 5,821
Annual Sales, $ 23,760 K
Annual Net Income, $ -13,550 K
Last Quarter Sales, $ 5,800 K
Last Quarter Net Income, $ -4,200 K
60-Month Beta 0.99
% of Insider Shareholders 9.20%
% of Institutional Shareholders 13.58%
Float, K 5,286
% Float 90.80%
Short Volume Ratio 0.13

Growth:

1-Year Return -11.60%
3-Year Return -34.62%
5-Year Return -53.30%
5-Year Revenue Growth 1,423.08%
5-Year Earnings Growth 41.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.91 on 11/15/22
Next Earnings Date 03/16/23
Earnings Per Share ttm -3.71
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -8.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 12/20/22

MDWD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -68.07%
Profit Margin % -57.03
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 2.95
Price/Cash Flow N/A
Price/Book 49.81
Book Value/Share 0.29
Interest Coverage -4.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar